John F. Burd, PhD
Chief Executive Officer
Dr. Burd has over 30 years of experience in glucose monitoring technology. Dr. Burd was the founder of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. DexCom has a market capitalization of more than $5 billion. Previously, Dr. Burd was CEO of Oculir, MiraMedica and LXN. Dr. Burd has authored and co-authored numerous articles and his work in the medical and biotechnology field has led to the filing and ownership of twenty-three patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.